To develop a new to market, self-test, ‘home usable’ biomarker panel test for common cancers based on a totally new technology, detecting a broader range of cancers and having a level of accuracy beyond any currently available alternatives.

To develop a new to market, wearable detection device, based on totally novel technology, for measuring Acute Coronary Syndrome biomarker concentrations without the need for blood vessel puncture, for constant, real-time monitoring of patients with cardiac disease.